Related Experiment Video

Updated: Feb 5, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.6K

NRAS mutant melanoma: an overview for the clinician for melanoma management

Russell W Jenkins1, Ryan J Sullivan1

  • 1Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Melanoma Management
|September 8, 2018
PubMed

Insights

NRAS mutations drive aggressive melanoma by activating key signaling pathways. New therapeutic strategies targeting these NRAS effector pathways are crucial for effective treatment of NRAS-mutant melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma incidence is rising globally, with NRAS mutations found in about 20% of cutaneous melanomas.
  • NRAS mutations are linked to aggressive disease and activate critical cancer growth pathways like PI3K/Akt and MEK-ERK.
  • Current treatments for NRAS-mutant melanoma are limited, despite promising preclinical findings.

Purpose of the Study:

  • To review the role of NRAS mutations in melanoma.
  • To discuss the signaling pathways affected by NRAS mutations.
  • To highlight the need for novel therapeutic strategies for NRAS-mutant melanoma.

Main Methods:

  • Literature review of NRAS mutations in melanoma.
  • Analysis of NRAS effector pathways (PI3K/Akt, MEK-ERK, RAL).
  • Comparison of current melanoma treatments.

Main Results:

  • NRAS mutations activate multiple pro-growth signaling cascades in melanoma cells.
  • Targeting NRAS effector pathways shows preclinical promise.
  • Effective therapies for NRAS-mutant melanoma are still lacking.

Conclusions:

  • Understanding NRAS effector signaling is key to developing new treatments.
  • Targeting downstream pathways, not NRAS directly, may be a viable strategy.
  • Further research is essential to identify optimal treatments for NRAS-mutant melanoma.
Keywords:
BRAFMEKNRASPD-1immunotherapymelanoma

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
436
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
218
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
173
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
650
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
543
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
294